European Cystic Fibrosis Society (ECFS)
Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study

Resource Type

CF Research News

Authors

Helen L. Barr, Nigel Halliday, David A. Barrett, Paul Williams, Douglas L. Forrester, Daniel Peckham, Kate Williams, Alan R. Smyth, David Honeybourne, Joanna L.Whitehouse, Edward F. Nash, Jane Dewar, Andrew Clayton, Alan J. Knox , Miguel Cámara
and Andrew W. Fogarty

References

J Cyst Fibros. 2016 Oct 20. pii: S1569-1993(16)30617-8

Document

PDF icon CF Research News article [1]

Link

Scientific abstract [2]

Date

Thursday, October 20, 2016

Featured resource article

Yes
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)

Source URL:https://www.ecfs.eu/resource-article/cf-research-news/diagnostic-and-prognostic-significance-systemic-alkyl-quinolones-p

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00189R1_FINAL_Barr_03112016.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Diagnostic%20and%20prognostic%20significance%20of%20systemic%20alkyl%20quinolones%20for%20P.%20aeruginosa%20in%20cystic%20fibrosis%3A%20a%20longitudinal%20study